Oncology Therapeutics Flashcards
Capecitabine
5-FU prodrug
Diarrhea, hand-foot syndrome
Give with food to decrease nausea
Avoid aluminum/magnesium antacids
Sun protection
CYP 2C9 interaction, warfarin concerns
Fluorouracil (5-FU)
Dihydropyrimidine dehydrogenase deficiency are more likely to experience toxicity
Mucositis, diarrhea,
Bolus - myelosuppression
Continuous - hand foot, mucositis, diarrhea
Need sun protection
Cytarabine
Ocular toxicity, profound myelosuppression, CNS toxicity if they start writing smaller and smaller
Vesicant
Vesicant cause tissue damage
Bendamustine CCC DDD MM Taxanes Vinca alkaloids
Cytarabine Vinca alkaloids (vincristine, vinblastine, vinorelbine) Paclitaxel Carmustine (BCNU) Mechlorethamine Bendamustine Cisplatin Doxorubicin, daunorubicin, mitoxantrone Dactinomycin
Gemcitabine
Yellow gem
Dose limiting myelosuppression
Dose reduce if elevated bilirubin
Elevated LFT enzymes
Azacitidine
Fresh AAA
Short stability, so fresh bags must be prepared every 2-3 hours
Fever
Hypoalbuminemia pts caution for hepatic coma
Acyclovir and antifungal prophylaxis
Decitabine
AE: thrombocytopenia, neutropenia
Antibiotic prophylaxis
Hematopoietic growth factors needed
Fludrabine
Fever
CNS toxicity: blindness, coma, death
Prophylaxis against opportunistic infections
Cladribine
Lymphopenia (myelosuppression)
Fever
Prophylaxis against opportunistic infections
Pentostatin
Pen Prophylaxis
Immunosuppression expected prophylaxis
Prophylaxis for opportunistic infections
Dose reduction in renal impairment
Methotrexate
For high doses of MTX, start sodium bicarbonate drip to alkinalize urine and prevent renal toxicity
Monitor hematology (myelosuppression), renal, hepatic, pulmonary function
DDI with protein bound drugs
NSAIDS decrease renal function and MTX clearance
Common interaction with Bactrim (trimethoprim is an antifolate)
Leucovorin
Reduced form of folic acid
Administer 24-48 hours after MTX doses >100mg/m2
Glucarpidase
Inactivates methotrexate useful if renal failure
Do not administer with leucovorin, wait 2 hours
Pemetrexed
Trex dex
Dose limiting neutropenia
Dexamethasone 4mg BID x 3 days to prevent/improve rash
Folate and Vit B supplement 1 week before and continue throughout therapy to decrease hematologic side effects, mucositis, and diarrhea
Plant derivatives
All are 3A4 substrates
affected by 3A4 inhibition
Vincalkaloids Taxanes Epotholones Camptothecans (irinotecan) Podophyllotoxins
VinCristine
Constipation due to neurotoxicity
Dose limiting neurotoxicity
Do NOT administer intrathecally
VinBlastine
BlastM
Bronchospasm
Myelosuppression
Monitor CBC w/differential
Vinorelbine
Vinca alkaloids peripheral neuropathy
Myelosuppression
Monitor CBC
Paclitaxel
Alopecia, peripheral neuropathy, myalgia, cardiac toxicity, hypotension
Nano - more sensory neuropathy
Use non-PVC(polyvinyl chloride) tubing
Premedicate with diphenhydramine, H2RA, and dexamethasone
Docetaxel
Dose premedicate D C
Dose limiting myelosuppression
Mucositis
Increased Liver LFT enzymes
Fluid retention
Corticosteroid and diphenhydramine premedicate to prevent hypersensitivity reaction and fluid retention
Use non-PVC tubing and bags
Cabazitaxel
Do not use in hepatic impairment
Premedicate with diphenhydramine and corticosteroids
Muse non-PVC tubing and bags
Ixabepilone
Neuropathy
Use DEHP-free tubing/bags
Lactated ringers only
Premedicate with diphenhydramine and steroid
Etoposide
Dose limiting myelosuppression
Concentration dependent stability issues
Use non-PVC tubing
Irinotecan
Early onset Diarrhea within 24hrs (I ran to can)
And delayed onset
Prevent/Treat early diarrhea with IV atropine NOT lomotil
Treat delayed onset with loperamide 4mg and 2mg q 2h until no bowel movement in 12 hours
Dose limiting myelosuppression and diarrhea
Nausea and vomiting
D5W diluent
Dose reduce with elevated bilirubin
Topotecan
TT renal
Dose limiting myelosuppression
Anemia: 50% require blood transfusion
Dose reduce in renal impairment
Erbulin mesylate
Prolongs QT interval
NO dextrose in the tubing or lines
Use normal saline
Carmustine (BCNU)
High dose: severe N/V
Dose limiting hepatotoxicity and pulmonary toxicity
Neurotoxicity
Lifetime dose limit: 1400mg/m2
Non-PVC tubing
Lomustine
Delayed myelosuppression (nadir 24-60days)
Take on empty stomach
Cyclophosphamide
Dose limiting myelosuppression
Hemorrhagic cystitis (bladder toxicity)
Secondary neoplasm
Frequent urination due to acrolein
Adequate hydration (3L/day) needed Administer drug in morning
Monitor urine output and urinalysis
Ifosfamide
Dose-limiting hemorrhagic cystitis
CNS toxicity: hallucinations
Must be administered with Mesna and continued after ifosfamide
Mechlorethamine (nitrogen mustard)
Pain in injection
Melphalan
MM
Administer orally on empty stomach
Mucositis
Bendamustine
Lymphocytopenia
Metabolized through CYP1A2
Monitor renal function
Procarbazine
PP carbz food
Dose-limiting N/V
Administer with food or after a meal
Photo sensitivity
DDI: tyramine foods (beer, fermented cheese) SSRI, alcohol
Temozolamide
TE Time Empty
Take same time daily to decrease N/V
Take on empty stomach
Dose limiting myelosuppression
Thiotepa
Dose limiting cognitive impairment
Ocular toxicity, Fever
Cisplatin
SEVERE Nausea/Vomiting
Renal toxicity, ototoxicity, peripheral neuropathy, anemia
Mix in saline, cis saline
Decrease renal toxicity with amifostine
Carboplatin
Platelet myelosuppression
Ototoxicity, nephrotoxicity
Dose = AUC x (GFR+25) 25 is no renal Cl
Oxaliplatin
Dose limiting peripheral neuropathy
Cold sensitivity
Prevention with gabapentin
Dilute/flush with Dextrose!
Anthracene derivatives
-rubi - red urine
And mitoxantrone
Vesicant
Doxorubicin
Irreversible cardiac damage
Total lifetime dose 500mg/m2
Reduce cardio toxicity with dexrazoxane
Daunorubicin
Lifetime dose 500mg/m2
Red urine
Epirubicin
EpiHepiFree
Lines must be flushed with a heparin free solution
5-FU is incompatible with epirubicin
Total lifetime dose: 900mg/m2
Mitoxantrone
Blue green color majoring urine, sclera, skin,
increase CV toxicity
Lifetime dose 160mg/m2
Bleomycin
Irreversible pulmonary toxicity
Lifetime dose 400 units
Use test dose, Do not Premedicate
Monitor pulmonary function
Dactinomycin
Vesicant
Pegylated-Aspariginase
PegPro
PEG formulation decreases dose and frequency of administration (q2 weeks)
Prolonged Prothrombin time
Decrease in fibrinogen and clotting factors
Test dose recommended
Monitor coagulation parameters
Hydroxyurea
Discard white powder floating on top
Take with food to decrease N/V
Corticosteroids
Can kill your lymphocytes and result in opportunistic infections
Total WBC may increase
AE: GI irritation, hyperglycemia, mood change, muscle weakness, immunosuppression, appetite change, adrenal corticoid insufficiency